Enthesis healing
US-2024390292-A1 · Nov 28, 2024 · US
US9636439B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9636439-B2 |
| Application number | US-6224508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 3, 2008 |
| Priority date | Sep 19, 2003 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method and device for the treatment of an aneurysm are provided. Different therapeutic agents are delivered to the aneurysmal site by a reservoir and delivery means in a localized, and, in some embodiments, time-released regimen, to treat, limit and reduce the severity of the aneurysm.
Opening claim text (preview).
The invention claimed is: 1. An aneurismal tissue treatment system comprising: a stent graft adapted for placement within a vessel lumen adjacent an aneurismal site; and at least one implantable therapeutic agent delivery reservoir adapted to be implanted external to said vessel lumen and further adapted to deliver a carrier comprising at least one therapeutic agent from said reservoir to said aneurismal site over time wherein said reservoir comprises said carrier and said at least one therapeutic agent within said reservoir, wherein said implantable therapeutic agent delivery reservoir comprises a pump. 2. The aneurismal tissue treatment system according to claim 1 wherein said pump is mechanical, electrical, or osmotic. 3. An aneurismal tissue treatment system, comprising: a stent graft adapted for placement within a vessel lumen adjacent an aneurismal site; and at least one implantable therapeutic agent delivery reservoir adapted to be implanted external to said vessel lumen and further adapted to deliver a carrier comprising at least one therapeutic agent from said reservoir to said aneurismal site over time wherein said reservoir comprises said carrier and said at least one therapeutic agent within said reservoir, wherein said at least one implantable therapeutic agent delivery reservoir delivers said at least one therapeutic agent to said aneurismal tissue by means of a pump and tubing for the treatment of said aneurismal tissue.
Stent-grafts · CPC title
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices · CPC title
having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Y-shaped blood vessels · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.